Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Receivables - Net (2018 - 2025)

Historic Receivables - Net for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $3.5 million.

  • Dna X's Receivables - Net fell 3324.43% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 3324.43%. This contributed to the annual value of $4.3 million for FY2024, which is 8303.49% down from last year.
  • Dna X's Receivables - Net amounted to $3.5 million in Q3 2025, which was down 3324.43% from $2.9 million recorded in Q2 2025.
  • Over the past 5 years, Dna X's Receivables - Net peaked at $30.3 million during Q3 2023, and registered a low of $2.8 million during Q3 2021.
  • In the last 5 years, Dna X's Receivables - Net had a median value of $10.8 million in 2021 and averaged $13.1 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first skyrocketed by 51386.7% in 2022, then crashed by 8303.49% in 2024.
  • Over the past 5 years, Dna X's Receivables - Net (Quarter) stood at $10.8 million in 2021, then skyrocketed by 107.66% to $22.4 million in 2022, then rose by 14.01% to $25.6 million in 2023, then crashed by 83.03% to $4.3 million in 2024, then dropped by 19.38% to $3.5 million in 2025.
  • Its Receivables - Net was $3.5 million in Q3 2025, compared to $2.9 million in Q2 2025 and $4.8 million in Q1 2025.